Obenshain Andrew - Insider Non-Derivative Transactions at bluebird bio, Inc. (BLUE) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 2, 2025, Obenshain Andrew's relationship to bluebird bio, Inc. (BLUE) is Director,Officer (President and CEO), and currently has 14,820 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BLUE insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Obenshain Andrew - Insider Non-Derivative Transactions of BLUE Common Stock

Obenshain Andrew - Insider Non-Derivative Transactions at BLUE

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jun 3, 2025	Disposition -- (Common Stock)	9300	0	0
Jun 3, 2025	Disposition -- (Common Stock)	14820	0	0
Jun 3, 2025	Acquisition -- (Common Stock)	14820	0	14820
May 31, 2025	U -- (Common Stock)	9027	0	9300
Mar 4, 2025	Sell -- (Common Stock)	921	3.92	18327
Feb 11, 2025	Acquisition -- (Common Stock)	763	0	19248
Feb 4, 2025	Sell -- (Common Stock)	86	7.39	18485
Jan 7, 2025	Sell -- (Common Stock)	140	9.24	18571
Dec 11, 2024	Sell -- (Common Stock)	971	0.42	374247
Oct 1, 2024	Sell -- (Common Stock)	34780	0.53	375218
Oct 1, 2024	Acquisition -- (Common Stock)	130000	0	409998
Mar 5, 2024	Sell -- (Common Stock)	6095	1.53	279998
Feb 6, 2024	Sell -- (Common Stock)	1879	0.9	286093
Jan 6, 2024	Sell -- (Common Stock)	3162	1.43	287972
Nov 4, 2023	Sell -- (Common Stock)	807	3.17	291134
Aug 11, 2023	Sell -- (Common Stock)	16929	3.54	291941
Mar 2, 2023	Acquisition -- (Common Stock)	67600	0	308870
Feb 2, 2023	F -- (Common Stock)	1420	6.38	241270
Jan 12, 2023	Sell -- (Common Stock)	3178	7.8	242690